In subsequent subgroup analyses, HSA infusion still did not affect the patients’ prognosis with significant hypoalbuminemia (<2.5 g/dl) while even tended to have an adverse effect on the group of patients with near-normal (3.0–3.5 g/dl) initial serum albumin levels. This evidence concerns the gene ALB and Hypoalbuminemia.